DE68918127D1 - Peptidbehandlung von hartnäckigen Infektionskrankheiten. - Google Patents

Peptidbehandlung von hartnäckigen Infektionskrankheiten.

Info

Publication number
DE68918127D1
DE68918127D1 DE68918127T DE68918127T DE68918127D1 DE 68918127 D1 DE68918127 D1 DE 68918127D1 DE 68918127 T DE68918127 T DE 68918127T DE 68918127 T DE68918127 T DE 68918127T DE 68918127 D1 DE68918127 D1 DE 68918127D1
Authority
DE
Germany
Prior art keywords
stubborn
infectious diseases
peptide treatment
peptide compound
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68918127T
Other languages
German (de)
English (en)
Inventor
Malcolm L Gefter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immulogic Pharmaceutical Corp
Original Assignee
Immulogic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharmaceutical Corp filed Critical Immulogic Pharmaceutical Corp
Application granted granted Critical
Publication of DE68918127D1 publication Critical patent/DE68918127D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68918127T 1988-02-10 1989-02-09 Peptidbehandlung von hartnäckigen Infektionskrankheiten. Expired - Lifetime DE68918127D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15486288A 1988-02-10 1988-02-10

Publications (1)

Publication Number Publication Date
DE68918127D1 true DE68918127D1 (de) 1994-10-20

Family

ID=22553124

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918127T Expired - Lifetime DE68918127D1 (de) 1988-02-10 1989-02-09 Peptidbehandlung von hartnäckigen Infektionskrankheiten.

Country Status (4)

Country Link
EP (1) EP0328390B1 (fr)
JP (1) JPH01301699A (fr)
AT (1) ATE111485T1 (fr)
DE (1) DE68918127D1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688914A (en) * 1989-08-18 1997-11-18 Institut Pasteur Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
US6080846A (en) * 1989-08-18 2000-06-27 Institut Pasteur Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
FR2650954B1 (fr) * 1989-08-18 1992-02-28 Pasteur Institut Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida
AU2012204955B2 (en) * 2011-01-06 2016-10-06 Bionor Immuno As Monomeric and multimeric immunogenic peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS256960B1 (en) * 1985-11-16 1988-04-15 Viktor Krchnak Peptides with properties of antigenic determinants and method of their production
ATE98376T1 (de) * 1986-03-24 1993-12-15 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
EP0247557B1 (fr) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag Peptides enveloppé HTLV-III(LAV)
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
EP0328390A3 (en) 1990-10-31
ATE111485T1 (de) 1994-09-15
JPH01301699A (ja) 1989-12-05
EP0328390B1 (fr) 1994-09-14
EP0328390A2 (fr) 1989-08-16

Similar Documents

Publication Publication Date Title
EP0330359A3 (fr) Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I
NO951903D0 (no) Terapeautisk anvendelse av chimeriske og radiomerkede antistoff mot humant B-lymfocyttbegrenset, differensierende antigen for behandling av B-celle lymfom
DE3854741T2 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
GB2255093A (en) Hiv-1 core protein fragments
ATE151638T1 (de) Verfahren und zubereitungen für die verwendung von hiv-env-polypeptiden und antikörpern
DK0499923T3 (da) Dentaladhæsiv
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
IL97709A0 (en) Peptides and pharmaceutical compositions for treating multiple sclerosis containing the same
ATE359089T1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis-b-virus
DE68918127D1 (de) Peptidbehandlung von hartnäckigen Infektionskrankheiten.
GB2250994B (en) Peptide fragments of hiv
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
DE69015314D1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
IT8349430A0 (it) Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
8332 No legal effect for de